throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner,
`
`v.
`
`NOVARTIS PHARMA AG,
`NOVARTIS TECHNOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owner.
`______________________
`
`Case No. IPR2021-00816
`U.S. Patent No. 9,220,631
`______________________
`
`PETITIONER’S THIRD OBJECTIONS TO
`ADMISSIBILITY OF EVIDENCE SUBMITTED BY PATENT OWNER
`
`
`
`
`
`
`
`
`

`

`Pursuant to 37 C.F.R. § 42.64(b), Petitioner Regeneron Pharmaceuticals, Inc.,
`
`IPR2021-00816
`U.S. 9,220,631
`
`
`
`
`hereby objects as follows to the admissibility of evidence filed by Patent Owners
`
`Novartis Pharma AG, Novartis Technology LLC, Novartis Pharmaceuticals
`
`Corporation, in conjunction with the Patent Owner Sur-Reply, filed on May 26, 2022.
`
`Evidence
`Exhibit 2335
`
`Objections
`FRE 105: To the extent that any portion of this exhibit may
`
`
`
`be deemed admissible, such admissibility should be for a
`
`limited purpose.
`
`FRE 402: The exhibit is not relevant to any ground upon
`
`which trial was instituted.
`
`FRE 403: The exhibit’s probative value to any ground upon
`
`which trial was instituted is substantially outweighed by the
`
`danger of unfair prejudice, confusing the issues, undue
`
`delay, wasting time, or needlessly cumulative evidence.
`
`FRE 802: The entirety of the exhibit is inadmissible hearsay
`
`if offered to prove the truth of any matter allegedly asserted
`
`therein.
`
`37 C.F.R. § 42.23(b): The exhibit is impermissibly filed as
`
`new evidence accompanying a sur-reply.
`
`
`
`2
`
`

`

`
`
`Evidence
`Exhibit 2336
`
`Objections
`FRE 105: To the extent that any portion of this exhibit may
`
`
`
`be deemed admissible, such admissibility should be for a
`
`IPR2021-00816
`U.S. 9,220,631
`
`limited purpose.
`
`FRE 402: The exhibit is not relevant to any ground upon
`
`which trial was instituted.
`
`FRE 403: The exhibit’s probative value to any ground upon
`
`which trial was instituted is substantially outweighed by the
`
`danger of unfair prejudice, confusing the issues, undue
`
`delay, wasting time, or needlessly cumulative evidence.
`
`FRE 802: The entirety of the exhibit is inadmissible hearsay
`
`if offered to prove the truth of any matter allegedly asserted
`
`therein.
`
`37 C.F.R. § 42.23(b): The exhibit is impermissibly filed as
`
`new evidence accompanying a sur-reply.
`
`Exhibit 2337
`
`FRE 105: To the extent that any portion of this exhibit may
`
`
`
`
`
`be deemed admissible, such admissibility should be for a
`
`limited purpose.
`
`FRE 402: The exhibit is not relevant to any ground upon
`
`which trial was instituted.
`
`3
`
`

`

`
`
`Evidence
`
`IPR2021-00816
`U.S. 9,220,631
`
`Objections
`FRE 403: The exhibit’s probative value to any ground upon
`
`which trial was instituted is substantially outweighed by the
`
`danger of unfair prejudice, confusing the issues, undue
`
`delay, wasting time, or needlessly cumulative evidence.
`
`FRE 802: The entirety of the exhibit is inadmissible hearsay
`
`if offered to prove the truth of any matter allegedly asserted
`
`therein.
`
`37 C.F.R. § 42.23(b): The exhibit is impermissibly filed as
`
`new evidence accompanying a sur-reply.
`
`Exhibit 2339
`
`Petitioner refers to the objections made during the
`
`
`
`deposition of James Agalloco, which are incorporated
`
`herein by reference.
`
`Exhibit 2340
`
`Petitioner refers to the objections made during the
`
`
`
`deposition of Joel M. Cohen, which are incorporated herein
`
`by reference.
`
`Exhibit 2341
`
`Petitioner refers to the objections made during the
`
`
`
`
`
`deposition of Kenneth S. Graham, which are incorporated
`
`herein by reference.
`
`4
`
`

`

`Evidence
`Exhibit 2342
`
`Objections
`FRE 105: To the extent that any portion of this exhibit may
`
`
`
`be deemed admissible, such admissibility should be for a
`
`IPR2021-00816
`U.S. 9,220,631
`
`limited purpose.
`
`FRE 403: The exhibit’s probative value to any ground upon
`
`which trial was instituted is substantially outweighed by the
`
`danger of unfair prejudice, confusing the issues, undue
`
`delay, wasting time, or needlessly cumulative evidence.
`
`FRE 802: The entirety of the exhibit is inadmissible hearsay
`
`if offered to prove the truth of any matter allegedly asserted
`
`therein.
`
`337 C.F.R. § 42.23(b): The exhibit is impermissibly filed as
`
`new evidence accompanying a sur-reply.
`
`Exhibit 2343
`
`FRE 105: To the extent that any portion of this exhibit may
`
`
`
`be deemed admissible, such admissibility should be for a
`
`limited purpose.
`
`FRE 403: The exhibit’s probative value to any ground upon
`
`which trial was instituted is substantially outweighed by the
`
`danger of unfair prejudice, confusing the issues, undue
`
`delay, wasting time, or needlessly cumulative evidence.
`
`5
`
`
`
`
`
`

`

`
`
`Evidence
`
`IPR2021-00816
`U.S. 9,220,631
`
`Objections
`FRE 802: The entirety of the exhibit is inadmissible hearsay
`
`if offered to prove the truth of any matter allegedly asserted
`
`therein.
`
`37 C.F.R. § 42.23(b): The exhibit is impermissibly filed as
`
`new evidence accompanying a sur-reply.
`
`Exhibit 2344
`
`FRE 105: To the extent that any portion of this exhibit may
`
`be deemed admissible, such admissibility should be for a
`
`limited purpose.
`
`FRE 403: The exhibit’s probative value to any ground upon
`
`which trial was instituted is substantially outweighed by the
`
`danger of unfair prejudice, confusing the issues, undue
`
`delay, wasting time, or needlessly cumulative evidence.
`
`FRE 802: The entirety of the exhibit is inadmissible hearsay
`
`if offered to prove the truth of any matter allegedly asserted
`
`therein.
`
`37 C.F.R. § 42.23(b): The exhibit is impermissibly filed as
`
`new evidence accompanying a sur-reply.
`
`
`
`6
`
`

`

`IPR2021-00816
`U.S. 9,220,631
`
`Evidence
`Exhibit 2345
`
`Objections
`Petitioner refers to the objections made during the
`
`
`
`deposition of Dr. Szilard Kiss, which are incorporated
`
`herein by reference.
`
`Exhibit 2346
`
`Petitioner refers to the objections made during the
`
`
`
`deposition of Gerrit Moyer, which are incorporated herein
`
`by reference.
`
`FRE 105: To the extent that any portion of this exhibit may
`
`be deemed admissible, such admissibility should be for a
`
`limited purpose.
`
`FRE 403: The exhibit’s probative value to any ground upon
`
`which trial was instituted is substantially outweighed by the
`
`danger of unfair prejudice, confusing the issues, undue
`
`delay, wasting time, or needlessly cumulative evidence.
`
`FRE 802: The entirety of the exhibit is inadmissible hearsay
`
`if offered to prove the truth of any matter allegedly asserted
`
`therein.
`
`37 C.F.R. § 42.23(b): The exhibit is impermissibly filed as
`
`new evidence accompanying a sur-reply.
`
`7
`
`
`
`
`
`

`

`IPR2021-00816
`U.S. 9,220,631
`
`Evidence
`Exhibit 2347
`
`Objections
`Petitioner refers to the objections made during the
`
`
`
`deposition of Horst Koller, which are incorporated herein by
`
`reference.
`
`Exhibit 2348
`
`Petitioner refers to the objections made during the
`
`
`
`deposition of Lisa Cameron, which are incorporated herein
`
`by reference.
`
`Exhibit 2349
`
`FRE 105: To the extent that any portion of this exhibit may
`
`
`
`be deemed admissible, such admissibility should be for a
`
`limited purpose.
`
`FRE 403: The exhibit’s probative value to any ground upon
`
`which trial was instituted is substantially outweighed by the
`
`danger of unfair prejudice, confusing the issues, undue
`
`delay, wasting time, or needlessly cumulative evidence.
`
`FRE 802: The entirety of the exhibit is inadmissible hearsay
`
`if offered to prove the truth of any matter allegedly asserted
`
`therein.
`
`37 C.F.R. § 42.23(b): The exhibit is impermissibly filed as
`
`new evidence accompanying a sur-reply.
`
`8
`
`
`
`
`
`

`

`Evidence
`Exhibit 2350
`
`Objections
`FRE 105: To the extent that any portion of this exhibit may
`
`
`
`be deemed admissible, such admissibility should be for a
`
`IPR2021-00816
`U.S. 9,220,631
`
`limited purpose.
`
`FRE 403: The exhibit’s probative value to any ground upon
`
`which trial was instituted is substantially outweighed by the
`
`danger of unfair prejudice, confusing the issues, undue
`
`delay, wasting time, or needlessly cumulative evidence.
`
`FRE 802: The entirety of the exhibit is inadmissible hearsay
`
`if offered to prove the truth of any matter allegedly asserted
`
`therein.
`
`37 C.F.R. § 42.23(b): The exhibit is impermissibly filed as
`
`new evidence accompanying a sur-reply.
`
`Exhibit 2351
`
`FRE 105: To the extent that any portion of this exhibit may
`
`
`
`be deemed admissible, such admissibility should be for a
`
`limited purpose.
`
`FRE 403: The exhibit’s probative value to any ground upon
`
`which trial was instituted is substantially outweighed by the
`
`danger of unfair prejudice, confusing the issues, undue
`
`delay, wasting time, or needlessly cumulative evidence.
`
`9
`
`
`
`
`
`

`

`
`
`Evidence
`
`IPR2021-00816
`U.S. 9,220,631
`
`Objections
`FRE 802: The entirety of the exhibit is inadmissible hearsay
`
`if offered to prove the truth of any matter allegedly asserted
`
`therein.
`
`37 C.F.R. § 42.23(b): The exhibit is impermissibly filed as
`
`new evidence accompanying a sur-reply.
`
`Exhibit 2352
`
`FRE 105: To the extent that any portion of this exhibit may
`
`
`
`be deemed admissible, such admissibility should be for a
`
`limited purpose.
`
`FRE 403: The exhibit’s probative value to any ground upon
`
`which trial was instituted is substantially outweighed by the
`
`danger of unfair prejudice, confusing the issues, undue
`
`delay, wasting time, or needlessly cumulative evidence.
`
`FRE 802: The entirety of the exhibit is inadmissible hearsay
`
`if offered to prove the truth of any matter allegedly asserted
`
`therein.
`
`37 C.F.R. § 42.23(b): The exhibit is impermissibly filed as
`
`new evidence accompanying a sur-reply.
`
`
`
`
`
`
`
`10
`
`

`

`
`Date: June 3, 2022
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2021-00816
`U.S. 9,220,631
`
`Respectfully submitted,
`
`
`/Anish R. Desai/
`Anish R. Desai (Reg. No. 73,760)
`Elizabeth S. Weiswasser (Reg. No. 55,721)
`Natalie Kennedy (Reg. No. 68,511)
`Andrew Gesior (Reg. No. 76,588)
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8000
`F: 212-310-8007
`E: Regeneron.IPR.Service@weil.com
`
`Christopher Pepe (Reg. No. 73,851)
`Robert T. Vlasis (admitted pro hac vice)
`Matthew D. Sieger (Reg. No. 76,051)
`Priyata Y. Patel (Reg. No. 76,861)
`Weil, Gotshal & Manges LLP
`2001 M Street NW, Suite 600
`Washington, DC 20036
`T: 202-682-7000
`F: 202-857-0940
`E: Regeneron.IPR.Service@weil.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`11
`
`

`

`
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on June 3, 2022, copies of the foregoing
`
`IPR2021-00816
`U.S. 9,220,631
`
`PETITIONER’S THIRD OBJECTIONS TO ADMISSIBILITY OF
`
`EVIDENCE SUBMITTED BY PATENT OWNER was served via electronic
`
`mail, upon the following:
`
`Elizabeth J. Holland
`Daniel P. Margolis
`Allen & Overy LLP
`1221 Avenue of the Americas
`New York, NY 10020
`elizabeth.holland@allenovery.com
`daniel.margolis@allenovery.com
`
`Nicholas K. Mitrokostas
`John T. Bennett
`Allen & Overy LLP
`1 Beacon Street
`Boston, MA 02108
`nicholas.mitrokostas@allenovery.com
`john.bennett@allenovery.com
`
`William G. James
`Allen & Overy LLP
`1101 New York Avenue, NW
`Washington, D.C 20005
`william.james@allenovery.com
`
`Linnea Cipriano
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`lcipriano@goodwinlaw.com
`
`
`
`
`
`12
`
`

`

`
`
`
`
`
`
`IPR2021-00816
`U.S. 9,220,631
`
`
`
`
`Duncan Greenhalgh
`Joshua Weinger
`Goodwin Procter LLP
`100 Northern Avenue
`Boston, MA 02210
`dgreenhalgh@goodwinlaw.com
`jweinger@goodwinlaw.com
`
`
`
`
`/Sandra Wong/
`Sandra Wong
`Senior IP Paralegal
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`212-310-8000
`sandra.wong@weil.com
`
`13
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket